Nikolaos Reskos sells SBLK shares under 10b5-1 plan (SBLK)

Rhea-AI Filing Summary

Morgan Stanley Smith Barney LLC submitted a Form 144 reporting insider sales of Common Stock by Nikolaos Reskos. The notice lists multiple 10b5-1 sales in May 2026 and earlier April 2026 entries, with individual transactions showing share counts and gross proceeds per trade.

Insights

Securities Compliance Attorney

Form 144 lists scheduled sales under a 10b5-1 plan and open-market dispositions.

Section 144 notices are administrative filings that report intended or completed sales by affiliates. The entries here include multiple 10b5-1 sales dated 05/18/2026–05/21/2026 with per-trade proceeds listed.

These notices do not themselves confirm settlement mechanics or whether transactions were effected under an exemptive plan; subsequent broker or Form 4/5 filings may show final settlement details.

Equity Markets Analyst

Reported sales are routine disclosures showing staged dispositions, not an earnings or corporate action.

The entries show multiple trades (example: $826,100.00 for 30,000 shares on 05/21/2026 and $868,179.15 for 33,103 shares on 05/18/2026), indicating staggered sales across dates.

Cash‑flow treatment and total holding context are not provided in the excerpt; further filings would clarify remaining beneficial holdings and settlement outcomes.

Key Figures

Sale on 05/21/2026: 30,000 shares Proceeds on 05/21/2026: $826,100.00 Sale on 05/18/2026: 33,103 shares +4 more

7 metrics

Sale on 05/21/2026 30,000 shares trade dated 05/21/2026

Proceeds on 05/21/2026 $826,100.00 gross proceeds listed for 30,000-share sale

Sale on 05/18/2026 33,103 shares trade dated 05/18/2026

Proceeds on 05/18/2026 $868,179.15 gross proceeds listed for 33,103-share sale

Sale on 05/20/2026 9,914 shares trade dated 05/20/2026

Proceeds on 05/20/2026 $263,234.55 gross proceeds listed for 9,914-share sale

April 2026 sales example 8,406 shares trade dated 04/15/2026

Key Terms

10b5-1, Form 144, Employee Stock Unit Award

3 terms

10b5-1 regulatory

"10b5-1 Sales for NIKOLAOS RESKOS 40 Agiou Konstantinou Street"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Employee Stock Unit Award financial

"Employee Stock Unit Award | Issuer | 5000 | 09/16/2020"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5000	136250.00	113424507	06/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/16/2020	Employee Stock Unit Award	Issuer			5000	09/16/2020	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for NIKOLAOS RESKOS 40 Agiou Konstantinou Street Maroussi J3 15124	Common	05/21/2026	30000	826100.00
10b5-1 Sales for NIKOLAOS RESKOS 40 Agiou Konstantinou Street Maroussi J3 15124	Common	05/20/2026	9914	263234.55
10b5-1 Sales for NIKOLAOS RESKOS 40 Agiou Konstantinou Street Maroussi J3 15124	Common	05/19/2026	86	2278.14
10b5-1 Sales for NIKOLAOS RESKOS 40 Agiou Konstantinou Street Maroussi J3 15124	Common	05/18/2026	33103	868179.15
NIKOLAOS RESKOS 40 Agiou Konstantinou Street Maroussi J3 15124	Common	04/15/2026	8406	210570.30
NIKOLAOS RESKOS 40 Agiou Konstantinou Street Maroussi J3 15124	Common	04/14/2026	1594	39850.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for SBLK show?

It reports multiple sales of Common Stock by Nikolaos Reskos under 10b5-1 arrangements. The notice lists dated trades with share counts and gross proceeds for each transaction, including entries in April and May 2026.

How many shares were sold on May 21, 2026 in the filing?

The filing shows a sale of 30,000 shares on 05/21/2026. That transaction lists gross proceeds of $826,100.00 for the 30,000-share sale in the excerpt provided.

Are the reported trades in the Form 144 part of a 10b5-1 plan?

Several entries are explicitly labeled as 10b5-1 sales in the excerpt. The filing text identifies some May 2026 transactions as "10b5-1 Sales," indicating scheduled plan-based dispositions for those rows.

Does the Form 144 state who received the sale proceeds?

No, the excerpt does not specify who received the cash proceeds. The listed rows show gross proceeds per trade but do not state the recipient party or how proceeds are applied.

Were there April 2026 sales reported in this Form 144?

Yes, the excerpt includes April entries: 8,406 shares on 04/15/2026 with $210,570.30 and 1,594 shares on 04/14/2026 with $39,850.00 shown in the notice.